Male underwent aquablation procedure.The treating physician was not able to reinsert the urinary catheter after the initial removal while the patient was in the pacu.The treating physician's initial assessment was that the original catheter was placed into a false urethral passage.Once the patient was brought back in the or, after clots/tissue evacuation, a false passage was identified.The treating physician performed minor rollerball cautery in the prostatic area on tissue before he irrigated the prostate area and re-inserted a balloon catheter.Patient passed his bladder voiding trial and was discharged home the next day.In addition, it was reported from the treating facility that the patient was doing well and had no adverse effects from the re-insertion of the balloon catheter.
|
H.10.Additional manufacturer narrative: a review of the aquabeam system's log file was conducted, which confirmed that there were no anomalies during the procedure.The review indicated that the system functioned as designed.A review of the device history record (dhr) for lot number 18c00529 was conducted, which confirmed that there were no nonconformances generated during the manufacturing process of this system, which could relate to the reported event.The review indicated that the system met all required specifications when released for distribution.The aquabeam system's instructions for use (ifu), ifu320301, lists urethral damage causing false passage or stricture as a potential perioperative risk of the aquablation procedure.Based on the review of the log file, dhr, and ifu, the event is considered not to be device related.Urethral damage causing false passage or stricture is a potential perioperative risk of the aquablation procedure.Submission of this report does not constitute an admission that the manufacturer's product caused or contributed to the event.
|